Zealand Pharma A/S
DelistedCIK 1674988fmd_16FE5VZGY437XCCT0FW3189405Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2021, 9 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|---|
| Total revenues | 183 | 231 | 136 | 38 | 41 | 353 | 293 |
| Cost of revenue | – | – | – | 0 | 0 | 91 | – |
| Gross profit | – | – | – | 35 | 41 | 263 | 174 |
| Research and development | 218 | 268 | 324 | 438 | 561 | 604 | 588 |
| Selling, general and administrative | – | – | – | 44 | 68 | 488 | 636 |
| Total operating expenses | – | – | – | 482 | 629 | 1,092 | 1,225 |
| Operating income | (86) | (119) | (249) | 652 | (588) | (792) | (1,052) |
| Interest expense | 42 | 44 | 34 | 37 | 3 | 49 | 16 |
| Income before taxes | (124) | (163) | (280) | 625 | (577) | (840) | (1,027) |
| Income tax expense | (6) | (6) | (6) | 44 | – | – | – |
| Net income from continuing operations | (118) | (157) | (274) | 581 | – | – | – |
| Net income | (118) | (157) | (274) | 581 | (572) | (847) | (1,018) |
| Net income to common shareholders | (114) | (157) | (274) | 581 | (572) | (847) | – |